I jordan

Review of Hikma Pharmaceuticals

Hikma Pharmaceuticals (Hikma Pharmaceuticals) is a...

Hikma Pharmaceuticals (Hikma Pharmaceuticals) is a multinational pharmaceutical company founded in 1978 in Jordan by Jordan's Samih Darwazeh, the first company of Arab origin to enter the US, British and European markets. And expanded and acquired factories in America, Portugal, Italy, Tunisia, Saudi Arabia, Egypt and Algeria, and extended to about 52 markets in the world. It was first listed on the London Stock Exchange as an international shareholding company in 2005, as well as the Dubai Stock Exchange. The original medicines are manufactured with the excellence of international companies and others with or without a brand. Its headquarters are in London today. It has many manufacturing sites in more than one Arab and foreign country. The company is committed to applying high quality standards or so-called GMP manufacturing practices.

The company's 23% growth in 2013, [1] and is the largest regional pharmaceutical company in the Middle East. [2]

Date modified

The company was founded by Samih Darwaza in Amman, Jordan in 1978. [3] In August 1996 it became the first Arab company to export its products to the United States. [4] The company was first listed on the London Stock Exchange in 2005. [3]

The company acquired many other companies and acquired the Biochemico Bavici Pharma Institute in Italy in 2005. [5] And Al Jazeera Pharmaceutical Industries in Saudi Arabia in 2006. [3] In 2007, the company went to buy APM in Jordan, [6] Alcan Pharma in Egypt, Thimorgan and Ripposfarm in Germany. [3] In May 2011, Al Hekma completed its acquisition of Baxter Healthcare in the United States. [7] [8]

In October 2011, Al Hikma entered the Moroccan market through the acquisition of Bromofarm, the ninth largest drug manufacturer in Morocco. [9] The company also opened a pharmaceutical company in Algeria with ALDAR Arabia.

Al Hikma has expanded its market in Egypt by acquiring the Egyptian Pharmaceutical and Chemical Industries Company (EPCI) in 2012